Enseval Putera Megatrading Tbk PT operates in the Drugs, proprietaries, and sundries sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Enseval Putera Megatrading Tbk PT with three other
drug stores in Asia:
Shandong Realcan Pharmaceutical Co Ltd
sales of 5.93 billion Chinese Renmimbi [US$968.09 million]
of which 100%
was Medical Devices Sales),
Hokuyaku Takeyama Holdings, Inc
(205.22 billion Japanese Yen [US$1.92 billion]
of which 75%
was Pharmaceutical Business), and
China National Medicines Corp., Ltd.
based in China
(10.08 billion Chinese Renmimbi [US$1.65 billion]
of which 101%
was Merchandise Selling).
Enseval Putera Megatrading Tbk PT reported sales of 15.62 trillion Indonesian Rupiahs (US$1.30 billion)
December of 2013.
increase of 16.8%
versus 2012, when the company's sales were 13.37 trillion Indonesian Rupiahs.
Sales at Enseval Putera Megatrading Tbk PT have increased during each of the previous five years
(and since 2008, sales have increased a total of 111%).
Sales of Other saw an increase
21.3% in 2013, from
1.85 trillion Indonesian Rupiahs to 2.24 trillion Indonesian Rupiahs.